This study describes the social and communicative strategies pharmaceutical companies use to influence NSAID prescribing behaviors and elicits physicians' perceptions and counterbalances to these strategies.
Aaron L. Woofter, MD
Advertisement
Articles by Aaron L. Woofter, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
3
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
4
Monoclonal Antibodies Had Varying Efficacy in Treating MG
5